NDAORALCAPSULE
Approved
Dec 2012
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
4/8 — Partial
Drug data last refreshed 18h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
JUXTAPID (lomitapide mesylate) is an oral capsule medication approved by the FDA on December 21, 2012, for the treatment of homozygous familial hypercholesterolemia (HoFH). It is a microsomal triglyceride transfer protein (MTP) inhibitor that reduces the production of apolipoprotein B-containing lipoproteins. The drug represents a targeted therapeutic approach for this rare genetic lipid disorder and addresses a significant unmet medical need in patients with severe, treatment-resistant hypercholesterolemia.
$0.0BPart D
15.2 years to LOEMechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Currently, zero open positions are linked to JUXTAPID in the dataset, indicating limited active hiring. Roles supporting this product would typically include rare disease specialists, orphan drug brand managers, and medical science liaisons (MSLs) with expertise in lipid disorders and HoFH management. Success in this space requires deep knowledge of rare disease patient populations, specialized healthcare provider networks, and regulatory frameworks governing orphan therapeutics.
Company
Worked on JUXTAPID at Chiesi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.